Ultragenyx Pharmaceutical Inc
F:UP0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Ultragenyx Pharmaceutical Inc
F:UP0
|
US |
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
R
|
Relx PLC
F:RDED
|
UK |
|
C
|
Cadeler A/S
F:CA2
|
DK |
|
Physicians Realty Trust
F:42O
|
US |
Wall St Price Targets
UP0 Price Targets Summary
Ultragenyx Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for UP0 is 61.39 EUR with a low forecast of 31.53 EUR and a high forecast of 116.54 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UP0's stock price target?
Price Target
61.39
EUR
According to Wall Street analysts, the average 1-year price target for UP0 is 61.39 EUR with a low forecast of 31.53 EUR and a high forecast of 116.54 EUR.
What is the Revenue forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
23%
The compound annual growth rate for Revenue over the next 8 years is 23%.
What is the Gross Profit forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
23%
The compound annual growth rate for Gross Profit over the next 7 years is 23%.
